BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11462058)

  • 1. Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression.
    Wagena EJ; Huibers MJ; van Schayck CP
    Thorax; 2001 Aug; 56(8):587-8. PubMed ID: 11462058
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapies for smoking cessation (antidepressants, nicotine-replacement and counseling) and implications for the treatment of patients with chronic obstructive pulmonary disease].
    Wagena EJ; Huibers MJ; van Schayck CP
    Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1492-6. PubMed ID: 11512420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients.
    Van Schayck CP; Kaper J; Wagena EJ; Wouters EF; Severens JL
    Addiction; 2009 Dec; 104(12):2110-7. PubMed ID: 19922576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.
    Wagena EJ; Knipschild PG; Huibers MJ; Wouters EF; van Schayck CP
    Arch Intern Med; 2005 Oct; 165(19):2286-92. PubMed ID: 16246996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
    Wing VC; Shoaib M
    Psychopharmacology (Berl); 2007 Dec; 195(3):303-13. PubMed ID: 17690868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of pharmacotherapies for smoking cessation during pregnancy.
    Benowitz NL; Dempsey DA; Goldenberg RL; Hughes JR; Dolan-Mullen P; Ogburn PL; Oncken C; Orleans CT; Slotkin TA; Whiteside HP; Yaffe S
    Tob Control; 2000; 9 Suppl 3(Suppl 3):III91-4. PubMed ID: 10982920
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.
    Quaak M; van Schayck CP; Postma DS; Wagena EJ; van Schooten FJ
    Addiction; 2012 Jan; 107(1):178-87. PubMed ID: 21658141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating tobacco addiction--nicotine or no nicotine?
    Benowitz NL
    N Engl J Med; 1997 Oct; 337(17):1230-1. PubMed ID: 9337385
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation.
    Hall SM; Lightwood JM; Humfleet GL; Bostrom A; Reus VI; Muñoz R
    J Behav Health Serv Res; 2005; 32(4):381-92. PubMed ID: 16215448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking cessation pharmacotherapy: a concise overview.
    Belcon AL
    Adv NPs PAs; 2011 Apr; 2(4):33-4. PubMed ID: 21661291
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bupropion: an effective new aid for smoking cessation].
    Wagena EJ; Zeegers MP; Huibers MJ; Chavannes NH; van Schayck CP
    Ned Tijdschr Geneeskd; 2001 Jan; 145(2):103-4. PubMed ID: 11225253
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatic therapy for major depressive disorder: selection of an antidepressant.
    Preskorn SH; Burke M
    J Clin Psychiatry; 1992 Sep; 53 Suppl():5-18. PubMed ID: 1522080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quit smoking is not just a matter or will].
    Duquet N
    J Pharm Belg; 2006; 61(4):105-10. PubMed ID: 17263191
    [No Abstract]   [Full Text] [Related]  

  • 14. Success rates for nortriptyline.
    Jiménez-Ruiz C; De Granda Orive JI
    Chest; 2003 Aug; 124(2):768-9; author reply 769. PubMed ID: 12907576
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of bupropion on depression symptoms in a smoking cessation clinical trial.
    Lerman C; Niaura R; Collins BN; Wileyto P; Audrain-McGovern J; Pinto A; Hawk L; Epstein LH
    Psychol Addict Behav; 2004 Dec; 18(4):362-6. PubMed ID: 15631608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation: integrating recent advances into clinical practice.
    Coleman T
    Thorax; 2001 Jul; 56(7):579-82. PubMed ID: 11413360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in the patient with COPD.
    Wilson I
    Int J Chron Obstruct Pulmon Dis; 2006; 1(1):61-4. PubMed ID: 18046903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nortriptyline-induced depression of ventilatory control in a patient with chronic obstructive pulmonary disease.
    Greenberg HE; Scharf SM; Green H
    Am Rev Respir Dis; 1993 May; 147(5):1303-5. PubMed ID: 8484648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease.
    Borson S; McDonald GJ; Gayle T; Deffebach M; Lakshminarayan S; VanTuinen C
    Psychosomatics; 1992; 33(2):190-201. PubMed ID: 1557484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results.
    Haggsträm FM; Chatkin JM; Sussenbach-Vaz E; Cesari DH; Fam CF; Fritscher CC
    Pulm Pharmacol Ther; 2006; 19(3):205-9. PubMed ID: 16517193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.